Contract Manufacturer – Page 41 – I wish I had more to offer

German FAZ: No Porsche production in Osnabrück from 2026007803

The VW factory in Osnabrück can no longer count on the hoped-for contract for an electric Porsche. “Business in China is currently notoriously difficult at Porsche. Therefore, overflow production for the Osnabrück plant can no longer be guaranteed in the future,” explained a VW spokesman when asked by the German Press Agency. The “Neue Osnabrücker… Continue reading German FAZ: No Porsche production in Osnabrück from 2026007803

Magna Announces Date for Q3 2024 Results Call

AURORA, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) — Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA INTERNATIONAL INC.THIRD QUARTER 2024 RESULTS WEBCAST FRIDAY – NOVEMBER 1, 20248:00 AM ET LIVE AUDIO WEBCASTWebcast registration: https://events.q4inc.com/attendee/431432937 DIAL IN DETAILS Participant Toll-Free Dial-In: 1-800-715-9871 Participant Toll Dial-In: 1-646-307-1963 Conference ID: 9829976 Slide presentation will be available on… Continue reading Magna Announces Date for Q3 2024 Results Call

@Groupe PSA: OP Revolution from Rüsselsheim000685

The Experimental GT from 1965 is the first concept car in the history of the European automotive industry, created in the first European design center. “There was a spirit of optimism at Opel, as there was last in 1928 when the rocket cars were built,” recalls former designer Erhard Schnell decades later. “We were young… Continue reading @Groupe PSA: OP Revolution from Rüsselsheim000685

Magna Announces Date for Q3 2024 Results Call

Gordon Moodie, Leading Public Company M&A Lawyer, Joins Debevoise as Partner

NEW YORK, Sept. 30, 2024 /PRNewswire/ — Debevoise & Plimpton LLP announces that Gordon Moodie, a senior mergers and acquisitions lawyer, is joining its New York office as a partner in the Mergers & Acquisitions Group and Public Company Advisory Group. A broad-gauged dealmaker and a sought-after advisor to corporate boards, Mr. Moodie will advise… Continue reading Gordon Moodie, Leading Public Company M&A Lawyer, Joins Debevoise as Partner

VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. – VRCA

NEW ORLEANS, Sept. 27, 2024 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Verrica Pharmaceuticals Inc. (NasdaqGM: VRCA). In December 2020, the Company submitted a New Drug Application (“NDA”) to the… Continue reading VERRICA PHARMACEUTICALS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Verrica Pharmaceuticals Inc. – VRCA

Aptiv Stock Declines 21% Year to Date: Is This a Buying Opportunity?

Aptiv PLC APTV has seen its stock decline 21.3% year to date, a significant drop compared to the 29.3% rally in the industry it belongs to and a 20.2% rise in the Zacks S&P 500 composite. This decline aligns with the performance of its closest competitors, Magna International MGA, which has fallen by 31.7% and… Continue reading Aptiv Stock Declines 21% Year to Date: Is This a Buying Opportunity?

Ford, GM shares fall after Morgan Stanley analyst downgrade

Shares of Ford Motor and General Motors fell around 5% after Morgan Stanley analysts downgraded the automakers. Shares of Ford Motor and General Motors fell about 5% on Wednesday after Morgan Stanley analysts downgraded the U.S. automakers, citing a challenging market environment marked by falling prices and growing competitive threats, particularly from China. Legacy U.S.… Continue reading Ford, GM shares fall after Morgan Stanley analyst downgrade

CereVasc Announces Journal of Molecular Therapy Publication Highlighting the eShunt® Platform as a CNS Gene Therapy Delivery Method

Gene therapy delivered via CereVasc’s endovascular delivery approach reached key targets in the central nervous system after injection into the cerebellopontine angle resulting in broad biodistribution The eShunt approach has the potential to provide doctors and biopharma partners with a safe, effective and minimally invasive alternative for delivering gene and cell therapies for neurological disorders… Continue reading CereVasc Announces Journal of Molecular Therapy Publication Highlighting the eShunt® Platform as a CNS Gene Therapy Delivery Method

Inside information: Valmet to supply a complete pulp mill with full-scope automation and flow control solutions to Arauco in Brazil

Valmet Oyj’s stock exchange release (inside information) on September 25, 2024 at 01:45 a.m. EEST ESPOO, Finland, Sept. 25, 2024 /PRNewswire/ — The Board of Directors of Arauco have today approved an investment of a complete pulp mill and selected Valmet as the supplier for the project. Valmet’s scope will be the delivery of complete pulp… Continue reading Inside information: Valmet to supply a complete pulp mill with full-scope automation and flow control solutions to Arauco in Brazil